行情

OXFD

OXFD

Oxford Immunotec
NASDAQ

实时行情|Nasdaq Last Sale

16.15
-0.06
-0.37%
盘后: 16.15 0 0.00% 16:00 01/17 EST
开盘
16.24
昨收
16.21
最高
16.27
最低
16.06
成交量
3.64万
成交额
--
52周最高
18.60
52周最低
12.49
市值
4.27亿
市盈率(TTM)
13.72
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

OXFD 新闻

  • 沪指震荡上扬 中国央行4天投放1.1万亿
  • 新浪财经.31分钟前
  • 不甘心5G落后,日本拟2030年实现“6G通信”
  • 参考消息.2小时前
  • 波音遇到软件新问题 737MAX复飞之路再遇挫折
  • 参考消息.3小时前
  • 英媒刊文:生产率下滑正困扰新兴经济体
  • 参考消息.4小时前

更多

所属板块

先进医疗设备和技术
+0.57%
医疗设备和用品
+0.29%

热门股票

名称
价格
涨跌幅

OXFD 简况

Oxford Immunotec Global PLC,is a diagnostics company. It is focused on developing and commercializing tests for under-served immune-regulated conditions. Its product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. It offers a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics. Tick-borne disease is the collective name for diseases passed to humans through the bite of an infected tick. Its diagnostic tests for tick-borne infections include multiple laboratory developed tests (LDTs). Its tick-borne disease tests utilize molecular methods (such as polymerase chain reaction) and techniques to prosecute the immune system. It has a series of assays for use in blood screening, building upon its expertise in tick-borne disease.
展开

Webull提供Oxford Immunotec Global PLC的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。